105 related articles for article (PubMed ID: 11444190)
21. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization.
Mirzamani N; Salehian P; Farhadi M; Tehran EA
Exp Mol Pathol; 2006 Dec; 81(3):231-4. PubMed ID: 16787643
[TBL] [Abstract][Full Text] [Related]
22. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus.
Vasef MA; Ferlito A; Weiss LM
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):348-56. PubMed ID: 9109729
[TBL] [Abstract][Full Text] [Related]
23. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
Pathmanathan R; Prasad U; Chandrika G; Sadler R; Flynn K; Raab-Traub N
Am J Pathol; 1995 Jun; 146(6):1355-67. PubMed ID: 7778675
[TBL] [Abstract][Full Text] [Related]
24. Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus.
Fan H; Nicholls J; Chua D; Chan KH; Sham J; Lee S; Gulley ML
Int J Cancer; 2004 Dec; 112(6):1036-41. PubMed ID: 15386346
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.
Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P
Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127
[TBL] [Abstract][Full Text] [Related]
26. [Detection of Epstein-Barr virus genomes in nasopharyngeal carcinoma].
Furukawa M; Murono S; Nakagawa S; Takeshita H; Yoshizaki T
Nihon Rinsho; 1997 Feb; 55(2):346-9. PubMed ID: 9046821
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
28. EBER oligonucleotide RNA in situ hybridization in EBV associated neoplasms.
Tornóczky T; Kelényi G; Pajor L
Pathol Oncol Res; 1998; 4(3):201-5. PubMed ID: 9761938
[TBL] [Abstract][Full Text] [Related]
29. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress.
Wong HL; Wang X; Chang RC; Jin DY; Feng H; Wang Q; Lo KW; Huang DP; Yuen PW; Takada K; Wong YC; Tsao SW
Mol Carcinog; 2005 Oct; 44(2):92-101. PubMed ID: 16086371
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathology parameters in human nasopharyngeal carcinoma.
Shi W; Pataki I; MacMillan C; Pintilie M; Payne D; O'Sullivan B; Cummings BJ; Warde P; Liu FF
Cancer; 2002 Apr; 94(7):1997-2006. PubMed ID: 11932902
[TBL] [Abstract][Full Text] [Related]
32. [Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].
He JH; Zong YS; Zhang M; Zhong BL; Liang YJ; Liang XM
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):234-7. PubMed ID: 12882689
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma.
Liang JH; Lu TX; Tian T; Wang L; Fan L; Xu J; Zhang R; Gong QX; Zhang ZH; Li JY; Xu W
Clin Microbiol Infect; 2015 Jun; 21(6):596-602. PubMed ID: 25743579
[TBL] [Abstract][Full Text] [Related]
35. EBER in situ hybridization differentiates carcinomas originating from the sinonasal region and the nasopharynx.
Hwang TZ; Jin YT; Tsai ST
Anticancer Res; 1998; 18(6B):4581-4. PubMed ID: 9891522
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients.
Suh N; Liapis H; Misdraji J; Brunt EM; Wang HL
Am J Surg Pathol; 2007 Sep; 31(9):1403-9. PubMed ID: 17721196
[TBL] [Abstract][Full Text] [Related]
38. p53 and nasopharyngeal carcinoma: a Malaysian study.
Hoe SL; Lee ES; Khoo AS; Peh SC
Pathology; 2009; 41(6):561-5. PubMed ID: 19900105
[TBL] [Abstract][Full Text] [Related]
39. Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization.
Chen PC; Pan CC; Yang AH; Wang LS; Chiang H
J Pathol; 2002 Aug; 197(5):684-8. PubMed ID: 12210090
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal carcinoma heterogeneity of DNA content identified on cytologic preparations.
Maohuai C; Chang AR; Lo D
Anal Quant Cytol Histol; 2001 Jun; 23(3):213-7. PubMed ID: 11444191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]